Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emerald Kalama Chemical is a leading global producer of specialty chemicals, specializing in benzoic acid, benzaldehyde, and downstream derivatives such as benzoate salts and antimicrobial agents. The company provides high-purity ingredients used as preservatives and chemical intermediates in the pharmaceutical, food and beverage, and consumer care industries. Its pharmaceutical-grade products, including sodium benzoate and benzoic acid, are manufactured under stringent quality standards for use in various medicinal formulations. In 2021, the company was acquired by LANXESS, where it now operates as part of the Flavors & Fragrances business unit. Emerald Kalama maintains a significant manufacturing footprint with key facilities in the United States and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emerald Kalama Chemical.